CD4 and neoplasm: Further analysis of tumor tissues and microenvironment lymphocytes showed that 1-MT significantly enhanced Th1cells CD3+CD4+CD25− alone and with TL/DC-TL (23.3%, 19.2%, and 21.6%) respectively in comparison to PBS (13.4%).